These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31604116)

  • 21. Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity.
    Aydogan Mathyk B; Aslan Cetin B; Vardagli D; Zengin E; Sofiyeva N; Irez T; Ocal P
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):194-199. PubMed ID: 29673660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous gonadotropins do not increase the blood-follicular transportation capacity of extra-ovarian hormones such as prolactin and cortisol.
    von Wolff M; Schneider S; Kollmann Z; Weiss B; Bersinger NA
    Reprod Biol Endocrinol; 2013 Sep; 11():87. PubMed ID: 24007293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin levels in follicular fluid as markers for IVF outcomes and predicting ovarian reserve.
    Tong J; Sheng S; Sun Y; Li H; Li WP; Zhang C; Chen ZJ
    Reproduction; 2017 Apr; 153(4):443-451. PubMed ID: 28062641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled ovarian hyperstimulation (COH) parameters associated with euploidy rates in donor oocytes.
    McCulloh DH; Alikani M; Norian J; Kolb B; Arbones JM; Munné S
    Eur J Med Genet; 2019 Aug; 62(8):103707. PubMed ID: 31252058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrafollicular inflammatory cytokines but not steroid hormone concentrations are increased in naturally matured follicles of women with proven endometriosis.
    Wu G; Bersinger NA; Mueller MD; von Wolff M
    J Assist Reprod Genet; 2017 Mar; 34(3):357-364. PubMed ID: 28074436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicular fluid soluble receptor for advanced glycation end-products (sRAGE): a potential indicator of ovarian reserve.
    Merhi Z; Irani M; Doswell AD; Ambroggio J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E226-33. PubMed ID: 24276462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of ovarian stimulation for IVF/ICSI on the antioxidant defence system and relationship to outcome.
    Palini S; Benedetti S; Tagliamonte MC; De Stefani S; Primiterra M; Polli V; Rocchi P; Catalani S; Battistelli S; Canestrari F; Bulletti C
    Reprod Biomed Online; 2014 Jul; 29(1):65-71. PubMed ID: 24813757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation.
    Appasamy M; Jauniaux E; Serhal P; Al-Qahtani A; Groome NP; Muttukrishna S
    Fertil Steril; 2008 Apr; 89(4):912-21. PubMed ID: 17681319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
    Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
    Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic profiling of human follicular fluid identifies potential biomarkers of oocyte developmental competence.
    O'Gorman A; Wallace M; Cottell E; Gibney MJ; McAuliffe FM; Wingfield M; Brennan L
    Reproduction; 2013 Oct; 146(4):389-95. PubMed ID: 23886995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R
    J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty Acids and Metabolomic Composition of Follicular Fluid Collected from Environments Associated with Good and Poor Oocyte Competence in Goats.
    Izquierdo D; Roura M; Pérez-Trujillo M; Soto-Heras S; Paramio MT
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant FSH and pregnancy-associated plasma protein.
    Choi D; Hwang SS; Lee EY; Park CE; Yoon BK; Lee JH; Bae DS
    Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):171-6. PubMed ID: 12860336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle.
    Haas J; Bassil R; Gonen N; Meriano J; Jurisicova A; Casper RF
    Reprod Biol Endocrinol; 2018 May; 16(1):54. PubMed ID: 29843716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of oxidative stress in the follicular fluid of infertility patients with an endometrioma.
    Nakagawa K; Hisano M; Sugiyama R; Yamaguchi K
    Arch Gynecol Obstet; 2016 Jan; 293(1):197-202. PubMed ID: 26246415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and follicular fluid leptin during in vitro fertilization: relationship among leptin increase, body fat mass, and reduced ovarian response.
    Bützow TL; Moilanen JM; Lehtovirta M; Tuomi T; Hovatta O; Siegberg R; Nilsson CG; Apter D
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3135-9. PubMed ID: 10487676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.
    Lindheim SR; Barad DH; Witt B; Ditkoff E; Sauer MV
    J Assist Reprod Genet; 1996 Oct; 13(9):745-7. PubMed ID: 8947826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.